Tyrosine Kinase Inhibitor (Hospital Clinic of Barcelona/Fundacio Clinic)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTyrosine Kinase Inhibitor (Hospital Clinic of Barcelona/Fundacio Clinic)
Drug Alias NameIQS20120527.01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHospital Clinic Of Barcelona (Es)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFundacio Clinic Per A La Recerca BiomedicaHospital Clinic Of Barcelona (Es)
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A